• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

C-Abl (ABL1) Antibody – Mouse Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS600727

Bcr-Abl hybrid gene product is a 210kD protein known to be assembled in K562 (human chronic myelogenous leukemia) cell line. c-Abl proto-oncogene encodes a nonreceptor type protein tyrosine kinase that is ubiquitously expressed and highly conserved in… More details

$1195 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
c-Abl (ABL1), Monoclonal Antibody
Full Product Name
c-Abl (ABL1, v-abl, Abelson Murine Leukemia Viral Oncogene Homolog 1, ABL, c-ABL, JTK7, p150, Proto-Oncogene Tyrosine-Protein Kanase ABL1, v-abl)
Product Gene Name
Product Synonym Names
Anti -c-Abl (ABL1, v-abl, Abelson Murine Leukemia Viral Oncogene Homolog 1, ABL, c-ABL, JTK7, p150, Proto-Oncogene Tyrosine-Protein Kanase ABL1, v-abl)
Immunogen Sequence
SH2 domain. MW of Antigen: 120kD.
Clonality
Monoclonal
Isotype
IgG1,g
Clone Number
2Q217
Host
Mouse
Species Reactivity
Human, Mouse
Form/Format
Supplied as a liquid in PBS, pH 7.4, 0.2% BSA, 0.09% sodium azide. Also supplied without BSA and sodium azide. See C0013-02AX.
Purity/Purification
Affinity Purified
Purified by Protein G affinity chromatography.
Specificity
Recognizes human c-Abl p120 and chimeric Bcr/Abl proteins.. Species crossreactivity: mouse.
Preparation and Storage
May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile 40-50% glycerol, aliquot and store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight
13,150 Da
Chromosome Location
chromosome: 9; Location: 9q34.1
3D Structure
ModBase 3D Structure for Q13915
Immunogen
Recombinant Abl protein. Cellular Localization: Cytoplasmic and nuclear Epitope: SH2 domain. MW of Antigen: 120kD.
Positive Control
HeLa cells or placenta

Product Categories/Family for anti-ABL1 antibody

Applications Tested/Suitable for anti-ABL1 antibody
Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC), Immunofluorescence (IF)
Application Notes for anti-ABL1 antibody
Dilution: Immunoprecipitation: 2ug/mg protein lysate (Use Protein G).
Western Blot: 1ug/ml for 2hrs at RT
Immunohistochemistry (Formalin/paraffin): 2-4ug/ml for 30 minutes at RT. Staining of formalin-fixed tissues requires boiling tissue sections in 1mM EDTA, pH 8 for 10-20 minutes followed by cooling at RT for 20 minutes.

Western Blot (WB) of anti-ABL1 antibody

Western Blot using MBS600727
Mouse Anti-ABL1 Monoclonal Antibody – Cat# MBS600727

Immunohistochemistry (IHC) of anti-ABL1 antibody

Formalin-fixed, paraffin-embedded human placenta stained with MBS600727 using peroxidase-conjugate and AEC chromogen. Note cytoplasmic staining of trophoblasts.
Mouse Anti-ABL1 Monoclonal Antibody, Immunohistochemistry (IHC) – Cat# MBS600727

Other Notes

Small volumes of anti-ABL1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for ABL1 purchase

MBS600727 is an antibody targeting ABL1. Also known as c-Abl (ABL1, v-abl, Abelson Murine Leukemia Viral Oncogene Homolog 1, ABL, c-ABL, JTK7, p150, Proto-Oncogene Tyrosine-Protein Kanase ABL1, v-abl). Reactive in Human, Mouse. Host: Mouse.

Additional Details

NCBI/Uniprot data below describe general gene information for ABL1. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
UniProt Primary Accession #
UniProt Related Accession #
NCBI Official Full Name
c-abl
NCBI Official Synonym Full Names
c-abl oncogene 1, non-receptor tyrosine kinase
NCBI Official Symbol
ABL1
NCBI Official Synonym Symbols
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL1
UniProt Protein Name
C-abl
UniProt Gene Name
ABL1
UniProt Entry Name
Q13915_HUMAN
NCBI Protein Information
tyrosine-protein kinase ABL1; proto-oncogene c-Abl; bcr/c-abl oncogene protein; c-abl oncogene 1, receptor tyrosine kinase; proto-oncogene tyrosine-protein kinase ABL1; v-abl Abelson murine leukemia viral oncogene homolog 1

NCBI Summary for ABL1

The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response. Activity of c-Abl protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. The t(9;22) translocation results in the head-to-tail fusion of the BCR (MIM:151410) and ABL1 genes present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1. The ABL1 gene is expressed as either a 6- or 7-kb mRNA transcript, with alternatively spliced first exons spliced to the common exons 2-11. [provided by RefSeq]
Show more

UniProt Comments for ABL1

Sequence similarities: Contains 1 SH3 domain. RuleBase RU003338

Research Articles on ABL1

1. Among 55 imatinib-resistant CML patients treated with dastinib or nilotinib, baseline mutations in the kinase domain disappeared in 8 patients & new mutations appeared in 9. T315I was the most frequently detected mutation.
2. Observational study of genetic testing. (HuGE Navigator)
3. Overexpression of c-ABL proto-oncogene is associated with enhanced resistance to tamoxifen in breast cancer.
4. Mounting evidence summarized in this review suggests that tyrosine kinase c-Abl and Fyn are critical in the neurodegenerative process which occurs in tauopathies.
5. Review of ABL1 fusion genes identified in T-cell acute lymphoblastic leukemia that provide proliferation and survival advantage to lymphoblasts.
6. Study suggests important roles of BCR-ABL gene expression and its native chromosomal locus for acquisition of BCR-ABL mutations and provides a new tool for further studying resistance mechanisms.
7. Endogenous c-Abl mediates endothelial apoptosis induced by inhibition of integrins alphavbeta3/alphavbeta5 or by LatB-induced disruption of F-actin.
8. The results show that Bcr-Abl regulates the actin cytoskeleton and non-apoptotic membrane blebbing via a GADS/Slp-76/Nck1 adaptor protein pathway.
9. the additive effects of imatinib and Everolimus on BCR-ABL-expressing cells are at least partly conditional upon the enhanced nuclear accumulation of p145 c-ABL
10. Studiies indicate that KD mutations conferring high-level imatinib resistance are present in patients with de novo CML and in some of them lead to disease progression.
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000